Studies of Platelet 5-Hydroxytryptamine (Serotonin) in Storage Pool Disease and Albinism
AUTOR(ES)
Weiss, Harvey J.
RESUMO
Platelets in patients with storage pool disease are markedly deficient in a nonmetabolic (storage) pool of ADP that is important in platelet aggregation. They are also deficient in ATP, although to a lesser degree. In seven patients with this disorder, including one with albinism, platelet 5-hydroxytryptamine (5-HT) levels were reduced in proportion to the reduction in ATP (r = 0.94). Their platelets show diminished capacity to absorb [14C]5-HT, and the type of defect was similar to that produced in normal platelets by reserpine, a drug known to inhibit the uptake of 5-HT by the platelet dense granules. Storage pool-deficient platelets also converted more [3H]5-HT to [3H]5-hydroxyindoleacetic acid than did normal platelets, and the platelets in one of two patients studied contained increased amounts of 5-HT metabolites. The above findings, together with those reported previously, support the conclusion that the capacity of the dense granules (which may be either diminished or functionally abnormal) for storing 5-HT is decreased in storage pool disease; as a result, the 5-HT that enters the platelet may be more exposed to monoamine oxidases present on mitochondrial membranes. This diminished storage capacity (for 5-HT) may also explain why preincubating platelet-rich plasma with 5-HT for 45 min without stirring inhibits subsequent platelet aggregation by 5-HT to a greater degree in patients with storage pool disease than in normal subjects. The latter finding is also consistent with the theory that the aggregation of platelets by 5-HT is mediated by the same receptors on the plasma membrane that are involved in its uptake. The diminished release of platelet-bound [14C]5-HT by collagen that we found in these patients, as well as findings in previous studies, suggests that the release reaction may also be abnormal in storage pool disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=301570Documentos Relacionados
- Fluorescence of protonated excited-state forms of 5-hydroxytryptamine (serotonin) and related indoles.
- 5-Hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache
- An assessment of platelet aggregation induced by 5-hydroxytryptamine: Part I After pre-incubation with 5-hydroxytryptamine and reserpine
- Raised 5-hydroxytryptamine concentrations in enterochromaffin cells in adult coeliac disease.
- NMR studies of 5-hydroxytryptamine transport through large unilamellar vesicle membranes.